Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pharvaris N.v. sell PlusUltra

Start price
€16.10
09.01.22 / 0%
Target price
-
09.01.23
Performance (%)
17.39%
Price
€13.70
16.12.21
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 17.39%. This prediction currently runs until 09.01.23. The prediction end date can be changed by PlusUltra at any time. This prediction was marked as speculative and is excluded from PlusUltra's performance statistics.
Performance without dividends (%)
Name 1w 1m
Pharvaris N.v. - -
iShares Core DAX® 0.330% 6.271%
iShares Nasdaq 100 3.850% 14.279%
iShares Nikkei 225® 2.861% 10.016%
iShares S&P 500 4.209% 12.539%

According to PlusUltra what are the pros and cons of Pharvaris N.v. for the foreseeable future?

Pros
Capable Management
Cons
Probably not worthwhile Investment
High valuation
Below average Marketposition

Comments by PlusUltra for this prediction

In the thread Discuss Pharvaris N.v.

Sell Pharvaris N.v.